Markku Anttila

Title: Markku Anttila: Innovator in Oral Drug Formulations

Introduction

Markku Anttila is a notable inventor based in Pajulantie, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug formulations. His work has the potential to impact the treatment of various medical conditions.

Latest Patents

Anttila holds a patent for "Oral formulations of ospemifene." This invention relates to a liquid or semisolid oral drug formulation comprising a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof, or a metabolite thereof, in combination with a pharmaceutically acceptable carrier. This innovation showcases his expertise in creating effective drug delivery systems.

Career Highlights

Markku Anttila is associated with Quatrx Pharmaceuticals Company, where he continues to advance his research and development efforts. His work at Quatrx has allowed him to collaborate with other professionals in the field, enhancing the impact of his inventions.

Collaborations

One of his notable coworkers is Veli-Matti Lehtola. Their collaboration exemplifies the importance of teamwork in the innovation process, as they work together to push the boundaries of pharmaceutical research.

Conclusion

Markku Anttila's contributions to oral drug formulations highlight his role as an innovator in the pharmaceutical industry. His patent for ospemifene formulations demonstrates his commitment to improving drug delivery methods.